University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug information and related clinical trials

Explore a comprehensive list of organizations, including their profiles and details.

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

DeepMed Research

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease

Not Applicable

Completed

Conditions: Alzheimer Disease

Interventions: Other: Deep brain stimulation

First Posted Date: 2010-03-26

Last Posted Date: 2013-06-07

Lead Sponsor: University of Cologne

Target Recruit Count: 6

Registration Number: NCT01094145

Locations: 🇩🇪
Uni-Klinik Köln AöR, Cologne, North Rhine Westphalia, Germany

Brilliant Blue Versus Indocyanine Green

Phase 3

Conditions: Macular Pucker
Macular Hole
Vitreoretinal Surgery

Interventions: Procedure: Indocyanine green
Procedure: Brilliant blue arm

First Posted Date: 2010-03-09

Last Posted Date: 2011-04-18

Lead Sponsor: University of Cologne

Target Recruit Count: 50

Registration Number: NCT01083004

Locations: 🇩🇪
Center of Ophthalmology, University of Cologne, Cologne, NRW, Germany

Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant

Phase 4

Terminated

Conditions: Lumbar Spinal Stenosis

Interventions: Other: physiotherapy
Procedure: Spacer

First Posted Date: 2010-01-27

Last Posted Date: 2016-11-06

Lead Sponsor: University of Cologne

Target Recruit Count: 22

Registration Number: NCT01057641

Locations: 🇩🇪
University Hospital Cologne, Cologne, NRW, Germany
🇩🇪
University Hospital of Cologne, Cologne, Germany

Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients

Phase 1

Completed

Conditions: Hodgkin Lymphoma

Interventions: Drug: Doxorubicine
Drug: DTIC
Drug: Lenalidomide
Drug: Vinblastine

First Posted Date: 2010-01-26

Last Posted Date: 2018-03-22

Lead Sponsor: University of Cologne

Target Recruit Count: 30

Registration Number: NCT01056679

Locations: 🇩🇪
1st Dept. of Medicine, Cologne University Hospital, Cologne, NRW, Germany

Molecular Imaging With Erlotinib and Bevacizumab

Phase 2

Completed

Conditions: Non-Small-Cell Lung Carcinoma

Interventions: Drug: Erlotinib, Bevacizumab
Drug: Fluoro-D-glucose
Drug: Fluoro-L-thymidine
Drug: Gadolinium-DPTA

First Posted Date: 2010-01-12

Last Posted Date: 2016-05-20

Lead Sponsor: University of Cologne

Target Recruit Count: 40

Registration Number: NCT01047059

Locations: 🇩🇪
Center for Integrated Oncology (CIO), University Hospital Cologne, Cologne, Northrhine-Westphalia, Germany

Influence of Whole Body Vibration Compared to Conventional Physiotherapy in Patients With Gonarthrosis

Completed

Conditions: Osteoarthritis

Interventions: Behavioral: Conventional physiotherapy
Behavioral: Whole body vibration

First Posted Date: 2009-12-23

Last Posted Date: 2011-10-12

Lead Sponsor: University of Cologne

Target Recruit Count: 40

Registration Number: NCT01037972

Locations: 🇩🇪
University Hospital of Cologne, Cologne, Germany

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Phase 1

Completed

Conditions: Lymphoma, Large-Cell, Anaplastic
Lymphoma, Non-Hodgkin
Disease, Hodgkin

Interventions: Drug: brentuximab vedotin

First Posted Date: 2009-12-04

Last Posted Date: 2014-12-12

Lead Sponsor: Seagen Inc.

Target Recruit Count: 52

Registration Number: NCT01026233

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 6 locations

Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkins Lymphoma

Interventions: Drug: 8 cycles BEACOPPesc plus oral contraceptive
Drug: 8 cycles BEACOPPesc plus Goserelin

First Posted Date: 2009-11-17

Last Posted Date: 2012-06-25

Lead Sponsor: University of Cologne

Target Recruit Count: 60

Registration Number: NCT01014507

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Phase 3

Completed

Conditions: Acquired Immunodeficiency Syndrome
HIV Infections

Interventions: Drug: Efavirenz plus Lamivudine/Zidovudine
Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine

First Posted Date: 2009-08-26

Last Posted Date: 2009-09-29

Lead Sponsor: University of Cologne

Target Recruit Count: 215

Registration Number: NCT00966160

Locations: 🇩🇪
Medical Clinic I and Department of Pharmacology, University of Cologne, Cologne, Germany

Cologne Esophageal Response Prediction Study (CERP-Study)

Not Applicable

Completed

Conditions: Esophageal Cancer

Interventions: Genetic: ERCC1 pathways analysis

First Posted Date: 2009-08-06

Last Posted Date: 2016-10-21

Lead Sponsor: Elfriede Bollschweiler

Target Recruit Count: 80

Registration Number: NCT00953511

Locations: 🇩🇪
Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, NRW, Germany

Prev
1
30
31
32
33
34
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy